T1	Pharmacological_substance 43 303	(1R,9S,12S,13R,14S,17R,18E,21S,23S,24R,25S,27R)-1,14-dihydroxy-12-(E)-2- [(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylvinyl-23,25-dimethoxy-13,19,21,27-tetramethyl-17-(2-oxopropyl)-11,28-dioxa-4-azatricyclo [22.3.1.0(4.9)]octacos-18-ene-2,3,10,16-tetrone
T3	Pharmacological_substance 305 311	FK1706
N1000 	Reference T3 MeSH:C505380	FK1706
T8	Pharmacological_substance 462 724	(1R,9S,12S,13R,14S,17R,18E,21S,23S,24R,25S,27R)-1, 14-dihydroxy-12-(E)-2- [(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylvinyl-23,25-dimethoxy-13,19,21,27-tetramethyl-17-(2-oxopropyl)-11,28-dioxa-4-azatricyclo  [22.3.1.0(4.9)]octacos-18-ene-2,3,10,16-tetrone
T9	Pharmacological_substance 726 732	FK1706
N1001 	Reference T9 MeSH:C505380	FK1706
T14	Pharmacological_substance 865 871	FK1706
N1002 	Reference T14 MeSH:C505380	FK1706
T15	Pharmacological_substance 1036 1042	FK1706
N1003 	Reference T15 MeSH:C505380	FK1706
T17	Pharmacological_substance 1095 1104	midazolam
N1004 	Reference T17 MeSH:D008874	midazolam
T19	Pharmacological_substance 1263 1269	FK1706
N1005 	Reference T19 MeSH:C505380	FK1706
T26	Pharmacological_substance 1555 1561	FK1706
N1006 	Reference T26 MeSH:C505380	FK1706
T28	Pharmacological_substance 1645 1654	midazolam
N1007 	Reference T28 MeSH:D008874	midazolam
T29	Pharmacological_substance 1771 1777	FK1706
N1008 	Reference T29 MeSH:C505380	FK1706
T31	Pharmacological_substance 1782 1791	midazolam
N1009 	Reference T31 MeSH:D008874	midazolam
T34	Pharmacological_substance 1920 1929	midazolam
N1010 	Reference T34 MeSH:D008874	midazolam
T37	Pharmacological_substance 2118 2124	FK1706
N1011 	Reference T37 MeSH:C505380	FK1706
T2	Subject 1143 1161	healthy volunteers
T13	Subject 388 394	humans
T7	Pharmacological_substance 322 362	nonimmunosuppressive immunophilin ligand
T10	Pharmacological_substance 743 783	nonimmunosuppressive immunophilin ligand
T54	Subject 966 971	human
